BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1002990)

  • 1. Relationship of functional levels of early components of complement to the H-2 complex of mice.
    Goldman MB; Goldman JN
    J Immunol; 1976 Nov; 117(5 Pt 1):1584-8. PubMed ID: 1002990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and activation of the early components of complement.
    Porter RR
    Fed Proc; 1977 Aug; 36(9):2191-6. PubMed ID: 328305
    [No Abstract]   [Full Text] [Related]  

  • 3. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.
    Pinckard RN; Olson MS; Giclas PC; Terry R; Boyer JT; O'Rourke RA
    J Clin Invest; 1975 Sep; 56(3):740-50. PubMed ID: 808560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 5. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor.
    Ji YH; Matsushita M; Okada H; Fujita T; Kawakami M
    J Immunol; 1988 Dec; 141(12):4271-5. PubMed ID: 3058802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
    Cunnion KM; Benjamin DK; Hester CG; Frank MM
    J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of lymphocyte proliferative responses to mitogens and antigens by complement components C1, C4 and C2.
    Laham MN; Caldwell JR; Panush RS
    J Clin Lab Immunol; 1982 Oct; 9(1):39-47. PubMed ID: 6983586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and biochemical properties of the early classical complement system of mice.
    Goldman MB; Bangalore S; Goldman JN
    J Immunol; 1978 Jan; 120(1):216-24. PubMed ID: 627718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H; Good RA; Day NK
    Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Direct reaction between complement system and cell nuclei (author's transl)].
    Peltier AP; Cyna L; Solal LC; Dryll A
    Ann Immunol (Paris); 1975; 126(2):177-89. PubMed ID: 172006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of complement factors in acute antibody-mediated rejection of mouse skin allografts.
    Berden JH; Capel PJ; Koene RA
    Eur J Immunol; 1978 Mar; 8(3):158-62. PubMed ID: 350593
    [No Abstract]   [Full Text] [Related]  

  • 13. C4 in glomerular lesions of NZB/NZW mice.
    Gabrielsen AE; Simmons AD; Rudofsky UH
    Clin Exp Immunol; 1977 Feb; 27(2):222-6. PubMed ID: 849653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between plasma and serum complement in patients with chronic liver disease.
    Inai S; Kitamura H; Fujita T; Kojima J; Nagaki K
    Clin Exp Immunol; 1976 Sep; 25(3):403-9. PubMed ID: 963909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic efficiency of cell-bound IgM: evidence that IgM-C1 complexes activate C4 molecules not hemolytic with homologous C2--C9.
    Ejzemberg R; Borsos T
    J Immunol; 1982 Apr; 128(4):1600-2. PubMed ID: 7061844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis of complement components.
    McPhaden AR; Lappin D; Whaley K
    J Clin Lab Immunol; 1982 May; 8(1):1-8. PubMed ID: 7047744
    [No Abstract]   [Full Text] [Related]  

  • 18. Venom of the ant Pseudomyrmex sp.: further characterization of two factors that affect human complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1977 Nov; 119(5):1690-9. PubMed ID: 410881
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alternate complement pathway in Behçet disease (author's transl)].
    Kogure M; Ono Y
    Nippon Ganka Gakkai Zasshi; 1975 Mar; 79(3):172-6. PubMed ID: 1171606
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of aspirin on the complement system in vitro.
    Hänsch GM; Voigtländer V; Rother U
    Int Arch Allergy Appl Immunol; 1980; 61(2):150-8. PubMed ID: 7351347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.